Get the Stockscreener App
4.13
0.00%
0.00
After Hours:
4.23
0.10
+2.42%
Lichen International Ltd stock is traded at $4.13, with a volume of 11,292.
It is up +0.00% in the last 24 hours and down -16.06% over the past month.
Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and sales of financial and taxation training software.
See More
Previous Close:
$4.13
Open:
$4.1513
24h Volume:
11,292
Relative Volume:
0.02
Market Cap:
$3.11M
Revenue:
$41.93M
Net Income/Loss:
$7.75M
P/E Ratio:
13.77
EPS:
0.3
Net Cash Flow:
$7.92M
1W Performance:
+3.77%
1M Performance:
-16.06%
6M Performance:
+2,225%
1Y Performance:
+177.18%
1-Day Range:
$4.00
$4.23
1-Week Range:
$3.7998
$4.3784
52-Week Range:
$0.0361
$8.28
Lichen International Ltd Stock (LICN) Company Profile
Name
Lichen International Ltd
Sector
Industry
Phone
-
Address
-
Compare LICN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LICN
Lichen International Ltd
|
4.13 | 3.11M | 41.93M | 7.75M | 7.92M | 0.30 |
|
RELX
Relx Plc Adr
|
53.91 | 97.15B | 11.99B | 2.46B | 2.70B | 1.3103 |
|
CTAS
Cintas Corporation
|
224.31 | 89.73B | 10.14B | 1.78B | 1.83B | 4.3175 |
|
TRI
Thomson Reuters Corp
|
201.67 | 87.75B | 7.27B | 2.16B | 1.86B | 4.79 |
|
CPRT
Copart Inc
|
49.64 | 48.62B | 4.59B | 1.48B | 1.18B | 1.52 |
|
RBA
Rb Global Inc
|
105.87 | 19.71B | 4.18B | 378.90M | 781.00M | 1.84 |
Lichen International Ltd Stock (LICN) Latest News
Lichen China (NASDAQ:LICN) Stock Price Down 1.8% – Here’s Why - Defense World
The Golden DregsA Joy Of International Revue + Sophie Jamieson + Lichen (Solo) - list.co.uk
(PDF) Lichen Planus Pigmentosus as a Cutaneous Extrahepatic Manifestation of Chronic Hepatitis C Virus Infection: A Case Report - researchgate.net
Lichen International Ltd (LICN) Is A Good Stock To Invest In - Stocksregister
Lipella Pharmaceuticals to Present Phase 2a Data for LP-310 - GlobeNewswire
Breakthrough Phase 2a Data: New LP-310 Treatment Cuts Oral Lichen Planus Pain by 65%, Exceeds Endpoints - Stock Titan
Market Might Still Lack Some Conviction On Lichen International Limited (NASDAQ:LICN) Even After 88% Share Price Boost - simplywall.st
Mixed Signals In US Markets As Inflation Data Looms - Finimize
Why Coinbase Global Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Form 6-KReport of foreign issuer [Rules 13a-16 and 15d-16] - ADVFN
Short Interest in Lichen China Limited (NASDAQ:LICN) Increases By 98.6% - Defense World
Lichen Planus Market Future Business Opportunities 2025-2032 | - openPR.com
Lipella Pharmaceuticals Abstract on Oral Lichen Planus - GlobeNewswire
Clinical Data: New Treatment Breakthrough for Oral Lichen PlanusPhase 2a Trial Shows Remarkable Improvement - Stock Titan
Lipella Reports Positive Phase 2a Results from Second LP-310 Cohort in Oral Lichen Planus; Final Data Expected Q2 2025 - The Manila Times
Lipella Reports Positive Phase 2a Results from Second - GlobeNewswire
(PDF) Histologically verified penile lichen sclerosus—Incidence in Denmark over 26 years and long‐term risk of penile and non‐penile cancer - ResearchGate
Biomarker Preservation in Antarctic Sandstones after Prolonged Space Exposure Outside the International Space Station During the ESA EXPOSE-E Lichens and Fungi Experiment - astrobiology.com
The Psychology of Astera Labs Inc Inc. (ALAB) Price Performance: Understanding Market Sentiment - investchronicle.com
Delphi Consensus on the Distinct Clinical and Histopathological Features of Lichen Planopilaris and Frontal Fibrosing Alopecia: Insights From the Hair Diseases EADV Task Force - Wiley Online Library
12 Industrials Stocks Moving In Tuesday's After-Market Session - Benzinga
Lipella Pharmaceuticals Completes Enrollment in Phase 2a Trial of LP-310 for Oral Lichen Planus - GlobeNewswire
Lichen International Announces Board Changes - MSN
LICN stock plunges to 52-week low, touches $3.7 amid steep decline - Investing.com Australia
LICN stock plunges to 52-week low, touches $3.7 amid steep decline By Investing.com - Investing.com South Africa
12 Industrials Stocks Moving In Wednesday's Pre-Market Session - Benzinga
12 Industrials Stocks Moving In Monday's Pre-Market Session - Benzinga
12 Industrials Stocks Moving In Friday's After-Market Session - Benzinga
12 Industrials Stocks Moving In Wednesday's After-Market Session - Benzinga
LICN stock touches 52-week low at $3.78 amid steep annual decline By Investing.com - Investing.com South Africa
LICN stock touches 52-week low at $3.78 amid steep annual decline - Investing.com India
Lichen China Ltd. Regains Nasdaq Compliance - TipRanks
12 Industrials Stocks Moving In Monday's Intraday Session - Benzinga
12 Industrials Stocks Moving In Friday's Pre-Market Session - Benzinga
LICN stock touches 52-week low at $4.5 amid sharp annual decline - Investing.com
LICN stock touches 52-week low at $4.5 amid sharp annual decline By Investing.com - Investing.com South Africa
Lichen China Limited will Change its Name to Lichen International Limited -March 03, 2025 at 12:00 am EST - MarketScreener
Lichen China (NASDAQ:LICN) Sets New 52-Week LowHere's What Happened - MarketBeat
LICN stock plunges to 52-week low, touches $5.21 amid steep decline - Investing.com
LICN stock plunges to 52-week low, touches $5.21 amid steep decline By Investing.com - Investing.com South Africa
Lichen International Ltd Stock (LICN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.23%
4.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):